Much has changed in the last 20 years in understanding how an individual’s DNA predicts common diseases, according to Sir Peter Donnelly, who cofounded in 2014 the company Genomics, of which he is CEO, in Oxford, England.
Category: Genomics, Finance, Investing, Operations, Life Sciences, Personalized medicine, Precision medicine, Analytics, Data Science, Business, Care, Data and Information
